REPLIGEN CORP Goodwill, Acquired During Period
REPLIGEN CORP (RGEN) reported Goodwill, Acquired During Period of $14.36 million for the 6-month period ending 2023-06-30, per its 10-Q/A filed 2024-11-18.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2024-11-18
- REPLIGEN CORP goodwill, acquired during period for the quarter ending 2019-09-30 was $22.00K.
- REPLIGEN CORP goodwill, acquired during period for fiscal 2015 was $161.00K, a 98.78% decline from fiscal 2014.
- REPLIGEN CORP goodwill, acquired during period for fiscal 2014 was $13.19M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2023-06-30 | $14.36M 10-Q/A · filed 2024-11-18 | |||
| 2019-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $142.90M 10-Q · filed 2019-10-31 | ||
| 2019-06-30 | $142.88M 10-Q · filed 2019-08-01 | |||
| 2015-12-31 | $161.00K 10-K · filed 2016-02-25 | |||
| 2014-12-31 | $13.19M 10-K · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |